Patrick Soon - Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner at ImmunityBio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
Stock Symbol
IBRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patrick Soon since 3/12/2024

Holdings reported by Patrick Soon for ImmunityBio, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32.6M $112M $3.42 Feb 22, 2025 Indirect
Common Stock 29.5M $101M $3.42 Feb 22, 2025 Direct
Common Stock 7.98M $27.3M $3.42 Feb 22, 2025 See footnte
Restricted Stock Units 229K $782K $3.42 Feb 22, 2025 Direct Common Stock
Stock Option (right to buy) 2.81M Feb 10, 2025 Direct Common Stock
Amended and Restated Promissory Note $0 Dec 10, 2024 Indirect Common Stock $0
Convertible Promissory Note $0 Dec 10, 2024 Indirect Common Stock
Second Amended and Restated Convertible Promissory Note $505M Dec 10, 2024 Indirect Common Stock

Transactions reported by Patrick Soon for ImmunityBio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.